1-8 of 8
Sun Jin Sym
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single and Tandem Autologous Peripheral Blood Stem Cell Transplantation for Patients with Multiple Myeloma: A Korean Multicenter Retrospective Study.

Sun Jin Sym, MD, Jae Yong Kwak, M.D., Chang Ki Min, M.D., Jong Ho Won, M.D., Seung-Tae Lee, M.D., Kihyun Kim, M.D., Cheolwon Suh, M.D.
Journal: Blood
Blood (2007) 110 (11): 5132.
https://doi.org/10.1182/blood.V110.11.5132.5132
Published: 2007
Journal Articles

Initial Cytoreductive Treatment with Thalidomide Plus Bolus Vincristine/Doxorubicin and Reduced Dexamethasone (T-bVAd) Followed by Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma.

Jae-Cheol Jo, Byung Wook Kang, Sun Jin Sym, Sung Sook Lee, Geundoo Jang, Dae Ho Lee, Sang-We Kim, Cheolwon Suh
Journal: Blood
Blood (2007) 110 (11): 5094.
https://doi.org/10.1182/blood.V110.11.5094.5094
Published: 2007
Journal Articles

A Multicenter Phase II Trial of Etoposide, Methylprednisolone, High-Dose Cytarabine, and Oxaliplatin (ESHAOx) for Patients with Refractory/Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Sun Jin Sym, MD, Hye Jin Kang, M.D., Seung-Hyun Nam, M.D., Hoyoung Kim, M.D., Seok Jin Kim, M.D., Hyeon Seok Eom, M.D., Won Seog Kim, M.D., Cheolwon Suh, M.D.
Journal: Blood
Blood (2007) 110 (11): 3446.
https://doi.org/10.1182/blood.V110.11.3446.3446
Published: 2007
Journal Articles

Multicenter Phase II Trial of 90 Y-Ibritumomab Tiuxetan with High-Dose Chemotherapy (Busulfan/Cyclophosphamide/Etoposide) Followed by Autologous Stem Cell Transplantation in Relapsed, Refractoried, or High-Risk B-Cell NHL.

Byung Woog Kang, Jae-Cheol Jo, Shin Kim, Geundoo Jang, Sung Sook Lee, Sun Jin Sym, Jin-Sook Ryu, Won Seog Kim, Sung Soo Yoon, Cheolwon Suh
Journal: Blood
Blood (2007) 110 (11): 1914.
https://doi.org/10.1182/blood.V110.11.1914.1914
Published: 2007
Journal Articles

A Phase I Trial of Bortezomib Plus CHOP Every 2 Weeks in Patients with Advanced Stage Diffuse Large B-Cell Lymphomas.

Geundoo Jang, MD, Sun-Jin Sym, MD, Shin Kim, Dae Ho Lee, MD, Sang We Kim, MD, Jooryung Huh, MD, Won Seog Kim, MD, Cheolwon Suh, MD
Journal: Blood
Blood (2007) 110 (11): 4446.
https://doi.org/10.1182/blood.V110.11.4446.4446
Published: 2007
Journal Articles

Mobilization of Peripheral Blood Stem Cells with Rituximab Plus ESHAP Combination Regimen in B-Cell NHL - Preliminary Results.

Min Kyoung Kim, MD, Shin Kim, R.N., Seong Sook Lee, M.D., Sun Jin Sym, M.D., Dae Ho Lee, M.D., Sang We Kim, M.D., Seongsoo Jang, M.D., Chan Jeong Park, M.D., Hyun Sook Chi, M.D., Joo Ryung Huh, M.D., Cheolwon Suh, M.D.
Journal: Blood
Blood (2006) 108 (11): 5443.
https://doi.org/10.1182/blood.V108.11.5443.5443
Published: 2006
Journal Articles

Ki-67 Expression Level Is Not a Significant Prognostic Factor in Korean Diffuse Large B-Cell Lymphoma.

Sun-Jin Sym, Sung Sook Lee, Min Kyoung Kim, Shin Kim, Cheolwon Suh
Journal: Blood
Blood (2006) 108 (11): 4631.
https://doi.org/10.1182/blood.V108.11.4631.4631
Published: 2006
Journal Articles

Treatment of Peripheral T-Cell Lymphoma (PTCL) with High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT).

Min Kyoung Kim, MD, Shin Kim, R.N., Seoung Sook Lee, M.D., Sun Jin Sym, M.D., Dae Ho Lee, M.D., Sang We Kim, M.D., Seongsoo Jang, M.D., Chan Jeong Park, M.D., Hyun Sook Chi, M.D., Joo Ryung Huh, M.D., Cheolwon Suh, M.D.
Journal: Blood
Blood (2006) 108 (11): 4682.
https://doi.org/10.1182/blood.V108.11.4682.4682
Published: 2006